22.45
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SDGR Giù?
Forum
Previsione
Schrodinger Inc Borsa (SDGR) Ultime notizie
Schrödinger to Announce Second Quarter 2025 Financial Results on August 6 | SDGR Stock News - GuruFocus
Schrödinger to Announce Second Quarter 2025 Financial Results on August 6 - Yahoo Finance
Is Schrödinger Inc. stock overhyped or has real potentialExceptional profit velocity - jammulinksnews.com
Schrodinger, Inc. (SDGR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - MSN
Is Schrödinger Inc. a good long term investmentPowerful market insights - Autocar Professional
Schrödinger Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
What drives Schrödinger Inc. stock priceTremendous gains - Autocar Professional
What analysts say about Schrödinger Inc. stockSuperior stock growth - jammulinksnews.com
Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration - Yahoo Finance
When the Price of (SDGR) Talks, People Listen - news.stocktradersdaily.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Ajax Therapeutics and Schrödinger expand JAK inhibitor collaboration By Investing.com - Investing.com Nigeria
Schrodinger stock maintains Buy rating at Citi on Ajax collaboration By Investing.com - Investing.com Canada
Schrodinger stock maintains Buy rating at Citi on Ajax collaboration - Investing.com
Ajax Therapeutics and Schrödinger expand JAK inhibitor collaboration - Investing.com
Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - Barchart.com
What makes Schrödinger Inc. stock price move sharplyMoney Making Low Risk Plans - beatles.ru
Morgan Stanley Assumes Coverage on Schrödinger (SDGR) Stock - MSN
BMO Capital Remains a Buy on Schrodinger (SDGR) - The Globe and Mail
(SDGR) On The My Stocks Page - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc.SDGR - FinancialContent
Schrödinger (SDGR) Receives FDA Fast Track Designation for Cancer Drug SGR-1505 - MSN
Schrodinger stock rating assumed by Morgan Stanley at Equalweight - Investing.com India
Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report - ReportAlert
Schrödinger gets Fast Track status for SGR-1505 - MSN
Schrödinger (SDGR) Gains FDA Fast Track for MALT1 Inhibitor - GuruFocus
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia | SDGR Stock News - GuruFocus
Schrödinger gets Fast Track status for SGR-1505 (SDGR:NASDAQ) - Seeking Alpha
Schrodinger Announces Board Elections and Approvals - TipRanks
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):